Invesco’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History

Invesco’s Portfolio EVLO Stock Details EVLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-577	Closed	-$39K	–	4195
2022 Q1	$39K	Buy	577 +8	+1%	+$666	﹤0.01%	3951
2021 Q4	$69K	Buy	569 +25	+5%	+$4.22K	﹤0.01%	3946
2021 Q3	$77K	Buy	+544	New	+$108K	﹤0.01%	3970
2021 Q2	–	Sell	-8,223	Closed	-$1.76M	–	4065
2021 Q1	$1.76M	Buy	8,223 +1,379	+20%	+$381K	﹤0.01%	2832
2020 Q4	$1.65M	Buy	+6,844	New	+$846K	﹤0.01%	2710

Other funds holding EVLO

Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

SOMRS

State of Michigan Retirement System Lansing, Michigan $22.6B AUM 40.24% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Harbourvest Partners Boston, Massachusetts $170M AUM 34.45% 1-Year Est. Return

CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco's EVLO Position: Q2 2022 in Review

Invesco sold out of Evelo Biosciences, Inc. Common Stock (EVLO) in Q2 2022, closing a stake of 577 shares — an estimated $39K sold.

Invesco first reported a position in EVLO in Q4 2020 and held it in 5 quarters. The position peaked at $1.76M in Q1 2021. 46 funds tracked by Wall St. Rank hold EVLO as of Q2 2022.

Invesco reported no remaining Evelo Biosciences, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Invesco sold 577 Evelo Biosciences, Inc. Common Stock shares in Q2 2022, an estimated $39K.
Invesco first reported a position in Evelo Biosciences, Inc. Common Stock in Q4 2020 and held it in 5 quarters.
Invesco's Evelo Biosciences, Inc. Common Stock position peaked at $1.76M in Q1 2021.
46 funds tracked by Wall St. Rank held Evelo Biosciences, Inc. Common Stock as of Q2 2022.

Based on Invesco's 13F filing for Q2 2022, filed 15 Aug 2022.